Published in Ugeskr Laeger on November 23, 1981
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62
Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol (1990) 1.41
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain (1989) 1.31
Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia (1989) 1.08
An anatomical heart model with applications to myocardial activation and ventricular mechanics. Crit Rev Biomed Eng (1992) 1.07
Prevalence and significance of muscle tenderness during common migraine attacks. Headache (1981) 1.04
Guidelines for controlled trials of drugs in tension-type headache: second edition. Cephalalgia (2010) 1.00
The blood-brain barrier in migraine treatment. Cephalalgia (2008) 0.99
Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia (1999) 0.99
Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship? Cephalalgia (1982) 0.98
Comparison of rizatriptan and sumatriptan: a reply to O'Quinn et al. Headache (1999) 0.98
The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol (Copenh) (1986) 0.96
The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve. Acta Pharmacol Toxicol (Copenh) (1980) 0.95
The common migraine attack may not be initiated by cerebral ischaemia. Lancet (1981) 0.94
Fractures of the femoral neck treated with a bipolar endoprosthesis. Clin Orthop Relat Res (1987) 0.92
Arterial responses during migraine headache. Lancet (1990) 0.92
Spreading cerebral oligemia in classical- and normal cerebral blood flow in common migraine. Headache (1982) 0.91
Tibiotalar torsion: bioengineering paradigm. Orthop Clin North Am (1976) 0.91
Guidelines for controlled trials of drugs in cluster headache. Cephalalgia (1995) 0.90
A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry (1980) 0.90
Keratoconus as a possible side-effect of acitretin (neotigason) therapy. Acta Derm Venereol (1993) 0.88
The headache-inducing effect of cilostazol in human volunteers. Cephalalgia (2006) 0.87
Treatment-emergent CNS symptoms following triptan therapy are part of the attack. Cephalalgia (2007) 0.87
Reduced contralateral hemispheric flow measured by SPECT in cerebellar lesions: crossed cerebral diaschisis. Acta Neurol Scand (1993) 0.86
Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther (1985) 0.86
Classic migraine. A prospective recording of symptoms. Acta Neurol Scand (1986) 0.85
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain (2008) 0.85
Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol (1986) 0.85
Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia (1984) 0.84
Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol (1992) 0.84
The effect of ergotamine and dihydroergotamine on cerebral blood flow in man. Stroke (1987) 0.83
[Joint charts in drug handling. Toward increased drug safety]. Ugeskr Laeger (2001) 0.83
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia (2000) 0.81
Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand (1984) 0.81
Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur Neurol (1980) 0.81
Prophylactic pharmacotherapy of migraine. Some practical guidelines. Neurol Clin (1997) 0.80
Interictal "patchy" regional cerebral blood flow patterns in migraine patients. A single photon emission computerized tomographic study. Eur J Neurol (1994) 0.80
A comment on time-to-event analysis for headache relief. Cephalalgia (2000) 0.80
Efficacy of beta-blockers in migraine. A critical review. Cephalalgia (1986) 0.80
Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol (1991) 0.80
Methodological aspects of drug trials in migraine. Neuroepidemiology (1985) 0.79
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine. Cephalalgia (2010) 0.79
Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. Eur J Clin Pharmacol (1982) 0.79
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine. Neurology (2001) 0.79
Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis. Mult Scler (1998) 0.79
Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Pharmacol Toxicol (Copenh) (1981) 0.78
Immunofluorescent and enzymatic staining of bile canaliculi in the same sections of the liver. Am J Clin Pathol (1972) 0.78
Clinical trial of nimodipine for single attacks of classic migraine. Cephalalgia (1985) 0.78
Bioavailability of sublingual ergotamine. Br J Clin Pharmacol (1982) 0.78
Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice. Cephalalgia (1995) 0.78
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in man. Acta Pharmacol Toxicol (Copenh) (1984) 0.78
Duration of the biological effect of ergotamine tartrate. Adv Neurol (1982) 0.78
Nitroglycerin provocation in normal subjects is not a useful human migraine model? Cephalalgia (2010) 0.78
Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol (1993) 0.78
Finding new drug targets for the treatment of migraine attacks. Cephalalgia (2009) 0.78
Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine. Cephalalgia (1986) 0.78
Lignocaine versus saline in migraine pain. Lancet (1980) 0.78
Small arteries can be accurately studied in vivo, using high frequency ultrasound. Ultrasound Med Biol (1993) 0.77
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Cephalalgia (2001) 0.77
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate. J Headache Pain (2008) 0.77
High Resolution 3D Imaging of Lung Tissue using Structured Light Microscopy. Conf Proc IEEE Eng Med Biol Soc (2005) 0.77
Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case. Eur J Clin Pharmacol (1982) 0.76
[Odontogenic keratocyst--a retrospective study of its clinical picture, radiology, pathohistology and therapy]. Schweiz Monatsschr Zahnmed (1984) (1986) 0.76
Lack of effect of GR43175 on peripheral arteries in man. Cephalalgia (1989) 0.76
Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography. Am J Psychiatry (1988) 0.76
Sumatriptan does not affect arteriovenous oxygen differences in jugular and cubital veins in normal human subjects. Cephalalgia (2008) 0.76
Chlormezanone in the treatment of migraine attacks: a double blind comparison with diazepam and placebo. Cephalalgia (1982) 0.76
[Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis]. Ugeskr Laeger (1999) 0.76
Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study. Cephalalgia (1983) 0.75
The fixed combination of acetylsalicylic acid, paracetamol and caffeine. Cephalalgia (2006) 0.75
Delayed hyperperfusion following migraine with a prolonged aphasic aura in a patient with CADASIL. Cephalalgia (2008) 0.75
Methodological aspects of prophylactic drug trials in migraine. Cephalalgia (1981) 0.75
Association between sumatriptan and stroke. Lancet (1993) 0.75
Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia (2000) 0.75
Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. Br J Clin Pharmacol (1983) 0.75
Posterior hypoperfusion in migraine without aura? Cephalalgia (2010) 0.75
Naratriptan is effective and well tolerated in the acute treatment of migraine. Neurology (1999) 0.75
Oral triptans vs. other classes of acute migraine medication. Cephalalgia (2006) 0.75
Presence of alpha-adrenoceptors in human temporal arteries. Comparison between migraine patients and controls. Cephalalgia (1983) 0.75
Meta-analysis of oral triptans. Cephalalgia (2004) 0.75
Oral sumatriptan. Neurology (1996) 0.75
Characterization of 5-hydroxytryptamine receptors in human temporal arteries: comparison between migraine suffers and nonsufferers. Ann Neurol (1982) 0.75
[Etiology of migraine]. Ugeskr Laeger (2000) 0.75
[Medicinal pain treatment in cancer and terminal conditions: nearly everyone can be maintained painfree until a few days before death]. Sygeplejersken (1979) 0.75
General and regional haemodynamic effects of intravenous ergotamine in man. Clin Sci (Lond) (1983) 0.75
Lactate and pyruvate determination in 50 mu-1 whole blood. Scand J Clin Lab Invest (1971) 0.75
Mechanism of ergotamine-induced decrease of peripheral systolic blood pressure in man. Acta Pharmacol Toxicol (Copenh) (1982) 0.75
Tolerability of naproxen sodium. Cephalalgia (1986) 0.75
Linear pharmacokinetics of intravenous ergotamine tartrate. Eur J Clin Pharmacol (1985) 0.75
[Root canal treatment of canal opening permanent incisors]. Tandlaegebladet (1973) 0.75
[Intracranial injury caused by a nail gun. Safety measures in handling pneumatic tools]. Ugeskr Laeger (1987) 0.75
[Drug therapy of pain in cancer and terminal illness]. Ugeskr Laeger (1979) 0.75
[Benign orgastic headache. Review and 6 cases]. Ugeskr Laeger (1979) 0.75
Local regulation of subcutaneous blood flow in normal subjects and in migraine patients before and after single-dose ergotamine tartrate. Clin Physiol (1982) 0.75
[Pharmacotherapy for migraine]. Nord Med (1985) 0.75
Action of some pericranial muscles during provoked attacks of common migraine. Pain (1982) 0.75
[Root canal therapy of permanent incisors with incomplete root formation]. Tandlaegebladet (1973) 0.75
Lack of effect of norepinephrine on cranial haemodynamics and headache in healthy volunteers. Cephalalgia (2009) 0.75
[Musculoskeletal symptoms and hyperlipoproteinemia type IV]. Ugeskr Laeger (1976) 0.75